hsa eligibility semaglutide medication Hims GLP-1 Weight Loss Guide 2026: Injectable and Oral Treatment Options for Men (Semaglutide and Tirzepatide) glp 1 medications fsa eligible
Description
Those seeking quick results might prefer injections, while others may find the oral option effective enough for their needs
Well, honestly, not much
Realistic Expectations: Long-Term Tirzepatide Weight Loss Outcomes Research from SUMO trials demonstrates that tirzepatide users lose 15-22% of baseline body weight over 68 weeks, with most significant losses occurring between months 3 and 6
The safety data in cancer patients looks reassuring so far, but it is still incomplete
